Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

被引：0
|
作者：
Dash, A. [1 ]
Pettus, J. A. [1 ]
Bochner, B. H. [1 ]
Dalbagni, G. [1 ]
Donat, S. M. [1 ]
Herr, H. W. [1 ]
Bajorin, D. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5077
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
    Chitikela, Sindhura
    Kumar, Lalit
    Sahoo, Ranjit K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10) : 956 - 956
  • [22] PATIENT REFUSAL OF NEO-ADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Filippou, Pauline
    Deal, Allison
    McCormick, Benjamin
    Narang, Gopal
    Nielsen, Matthew
    Pruthi, Raj
    Wallen, Eric
    Tan, Hung-Jui
    Woods, Michael
    Smith, Angela
    JOURNAL OF UROLOGY, 2017, 197 (04) : E125 - E126
  • [23] Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Urabe, Fumihiko
    Suzuki, Hirotaka
    Iwatani, Kosuke
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1107 - 1107
  • [24] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
    Funada, Satoshi
    Luo, Yan
    LANCET ONCOLOGY, 2020, 22 (06) : E236 - E236
  • [25] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
    Rizzo, Alessandro
    Mollica, Veronica
    Massari, Francesco
    LANCET ONCOLOGY, 2021, 22 (06) : E237 - E237
  • [26] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Galsky, Matthew D.
    Pal, Sumanta K.
    Chowdhury, Simon
    Harshman, Lauren C.
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Powles, Thomas
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    CANCER, 2015, 121 (15) : 2586 - 2593
  • [27] Clinical effectiveness of tislelizumab combined with gemcitabine/cisplatin (GC) versus GC as adjuvant therapy in high-risk muscle-invasive urothelial carcinoma (MIUC): A real-world study
    Tan, X.
    Wu, Z.
    Wang, Y.
    Yao, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1560 - S1560
  • [28] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [29] Neo-adjuvant chemotherapy in invasive bladder cancer
    Sternberg, CN
    Calabrò, F
    WORLD JOURNAL OF UROLOGY, 2001, 19 (02) : 94 - 98
  • [30] Neo-adjuvant chemotherapy in invasive bladder cancer
    Cora N. Sternberg
    Fabio Calabrò
    World Journal of Urology, 2001, 19 : 94 - 98
12345